Devyser Diagnostics Investor Relations Material
Latest events
Q3 2023
Devyser Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Devyser Diagnostics AB provides diagnostic kits for DNA testing within hereditary diseases, oncology, and transplantation. The company offers products in the areas of transplantation, thalassemia, oncology, fetal RHD screening non-invasive prenatal testing, hereditary, cystic fibrosis, cardiovascular and male infertility testing, as well as rapid aneuploidy analysis. Its products are used to guide targeted cancer therapies; enable rapid prenatal diagnostics; and in post-transplant follow-up.
Key slides for Devyser Diagnostics
Q3 2023
Devyser Diagnostics
Q4 2022
Devyser Diagnostics
Latest articles
Marvel-ous Reporting: Marvel’s Comic Inspired Reports
Shareholder reports are often considered tedious and dry. However, in the late 1980s and early 1990s, Marvel Comics revolutionized this perception by transforming its financial reports into captivating comic books.
8 Dec 2023
The Payments Value Chain: A Complex Ecosystem
The payments industry is a complex and dynamic field involving multiple key players. These include customers, merchants, issuers, acquirers, card networks, and various other entities together forming the payments value chain.
8 Dec 2023
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
Ticker symbol
DVYSR
Country
🇸🇪 Sweden